A phase III, multicentric, randomized single-blind study to evaluate the safety and the immunogenicity of El-Shaddai Biologicals varicella zoster vaccine in comparison to GlaxoSmithKline Biologicals Varilrixin healthy subjects aged 1 to 12 years.

Trial Profile

A phase III, multicentric, randomized single-blind study to evaluate the safety and the immunogenicity of El-Shaddai Biologicals varicella zoster vaccine in comparison to GlaxoSmithKline Biologicals Varilrixin healthy subjects aged 1 to 12 years.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Varicella zoster virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Nov 2011 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 08 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top